SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
Matthew D. Figley(Washington University in St. Louis), Thomas Ve(Griffith University), Xinying Jia(The University of Queensland), Aaron DiAntonio(Washington University in St. Louis), Mehdi Mobli(The University of Queensland), M.K. Manik(Boston Children's Hospital), Weixi Gu(The University of Queensland), Forhad Karim Saikot(The University of Queensland), Yun Shi(Griffith University), Lauren E. Hartley‐Tassell(Griffith University), Boštjan Kobe(The University of Queensland), Todd Bosanac(Eli Lilly (United States)), Katie Cunnea(Evotec (Germany)), Helen Y. McGuinness(The University of Queensland), Alpeshkumar K. Malde(Griffith University), Robert Hughes(Scripps Research Institute), Michael J. Landsberg(The University of Queensland), Veronika Masic(Griffith University), Tamim Mosaiab(Griffith University), Yo Sasaki(SHOWA Medical University), Philip S. Kerry(Evotec (Germany)), Syndee Holt(Griffith University), Jeffrey Milbrandt(James S. McDonnell Foundation), Zhenyao Luo(The University of Queensland), Jeffrey D. Nanson(The University of Queensland)
Cited by 339
Related Papers
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899